Free Trial

Modular Medical (MODD) Competitors

Modular Medical logo
$0.71 +0.00 (+0.55%)
As of 02:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

MODD vs. LNSR, PTHL, RCEL, PDEX, KRMD, BSGM, LAKE, LUCD, INFU, and OBIO

Should you be buying Modular Medical stock or one of its competitors? The main competitors of Modular Medical include LENSAR (LNSR), Pheton (PTHL), Avita Medical (RCEL), Pro-Dex (PDEX), KORU Medical Systems (KRMD), Biosig Technologies (BSGM), Lakeland Industries (LAKE), Lucid Diagnostics (LUCD), InfuSystem (INFU), and Orchestra BioMed (OBIO). These companies are all part of the "medical equipment" industry.

Modular Medical vs. Its Competitors

LENSAR (NASDAQ:LNSR) and Modular Medical (NASDAQ:MODD) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, institutional ownership, valuation, risk, dividends and media sentiment.

LENSAR currently has a consensus target price of $15.00, suggesting a potential upside of 14.68%. Given LENSAR's stronger consensus rating and higher probable upside, analysts clearly believe LENSAR is more favorable than Modular Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LENSAR
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Modular Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Modular Medical has lower revenue, but higher earnings than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LENSAR$53.49M2.88-$31.40M-$4.85-2.70
Modular MedicalN/AN/A-$18.82M-$0.51-1.40

40.2% of LENSAR shares are owned by institutional investors. Comparatively, 27.5% of Modular Medical shares are owned by institutional investors. 38.5% of LENSAR shares are owned by company insiders. Comparatively, 20.5% of Modular Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, LENSAR had 1 more articles in the media than Modular Medical. MarketBeat recorded 2 mentions for LENSAR and 1 mentions for Modular Medical. LENSAR's average media sentiment score of 1.87 beat Modular Medical's score of 1.87 indicating that LENSAR is being referred to more favorably in the media.

Company Overall Sentiment
LENSAR Very Positive
Modular Medical Very Positive

LENSAR has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500. Comparatively, Modular Medical has a beta of 0.17, suggesting that its stock price is 83% less volatile than the S&P 500.

Modular Medical has a net margin of 0.00% compared to LENSAR's net margin of -99.17%. Modular Medical's return on equity of -178.13% beat LENSAR's return on equity.

Company Net Margins Return on Equity Return on Assets
LENSAR-99.17% -737.30% -81.69%
Modular Medical N/A -178.13%-151.42%

Summary

LENSAR beats Modular Medical on 9 of the 14 factors compared between the two stocks.

Get Modular Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for MODD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MODD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MODD vs. The Competition

MetricModular MedicalMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$38.73M$10.45B$5.72B$9.52B
Dividend YieldN/A2.00%4.60%3.99%
P/E Ratio-1.4017.0428.0720.02
Price / SalesN/A27.34462.58104.32
Price / CashN/A23.2136.5558.97
Price / Book1.703.698.645.90
Net Income-$18.82M$234.77M$3.24B$258.50M
7 Day Performance3.48%6.07%4.08%2.12%
1 Month Performance-11.85%8.01%10.68%12.62%
1 Year Performance-53.33%-13.86%34.47%19.25%

Modular Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MODD
Modular Medical
0.9423 of 5 stars
$0.71
+0.5%
N/A-54.8%$38.73MN/A-1.4020Positive News
Gap Up
LNSR
LENSAR
1.3651 of 5 stars
$12.95
+0.4%
$15.00
+15.8%
+149.1%$152.62M$53.49M-2.67110Positive News
PTHL
Pheton
N/A$22.64
+5.2%
N/AN/A$146.05M$450K0.0011Positive News
Gap Up
High Trading Volume
RCEL
Avita Medical
1.363 of 5 stars
$5.49
-6.6%
$16.50
+200.5%
-40.6%$145.89M$64.25M-2.52130Gap Up
PDEX
Pro-Dex
2.4819 of 5 stars
$44.13
-4.5%
$56.00
+26.9%
+159.2%$143.86M$53.84M15.76140Positive News
KRMD
KORU Medical Systems
2.8962 of 5 stars
$3.07
-4.8%
$4.50
+46.8%
+37.1%$141.42M$33.65M-27.8680
BSGM
Biosig Technologies
1.9527 of 5 stars
$4.75
-13.0%
$10.00
+110.5%
+906.6%$130.08M$40K0.0050Gap Up
High Trading Volume
LAKE
Lakeland Industries
4.7538 of 5 stars
$13.62
-1.2%
$26.00
+90.9%
-36.6%$129.65M$177.65M-4.532,100
LUCD
Lucid Diagnostics
2.7086 of 5 stars
$1.17
-0.4%
$3.55
+204.7%
+29.4%$126.04M$4.17M-0.8770
INFU
InfuSystem
3.3158 of 5 stars
$5.52
-1.6%
$13.00
+135.5%
N/A$116.03M$137.58M92.03410News Coverage
Analyst Forecast
Analyst Revision
OBIO
Orchestra BioMed
3.0973 of 5 stars
$2.94
-3.0%
$14.20
+383.0%
-59.8%$112.25M$2.64M-1.654News Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:MODD) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners